Cyrus IdeS
IgG-driven Autoimmune Diseases (e.g., gMG, ITP)
PreclinicalActive
Key Facts
Indication
IgG-driven Autoimmune Diseases (e.g., gMG, ITP)
Phase
Preclinical
Status
Active
Company
About Cyrus Biotechnology
Cyrus Biotechnology is a private, preclinical-stage biotech leveraging a proprietary computational protein design platform to discover and develop novel biologics. The company has validated its platform through over 30 discovery programs with partners and is advancing a focused internal pipeline targeting large markets in autoimmune diseases. Its core strategy involves computationally optimizing natural proteins, such as enzymes and cytokines, to create therapeutics with superior pharmacological properties.
View full company profile